The European Society for Medical Oncology (ESMO) is organising the first European Lung Cancer Conference from 23 to 26 April in Geneva, Switzerland.

Lung cancer is globally recognised as a big killer and it is undoubtedly a leading cause of cancer deaths in Europe and in the world. Researchers provide evidence of advancements which lead to
continuous improvements in possible treatments of lung cancer and offer contributions to change the political and social environment for more pro-active prevention initiatives. The meeting will
highlight the following topics:
– the future of imaging;
– IASLC staging report of lung cancer;
– advances in surgical techniques for in-situ carcinoma;
– controversies on new radiotherapy techniques associated to surgery;
– novel curative treatments for early disease;
– targeted therapies and selection of patients on genomic analyses;
– toxicity management;
– identification of new diseases: is adenocarcinoma a cancer or not;
– tobacco policy.

The ESMO is a European non-profit professional organisation for medical oncology, with a focus on promoting multidisciplinary cancer treatment around the world.

For further information, please visit:
http://www.esmo.org/activities/jntconf/jntlung/